Full Text
Amnog Benefit Assessment for Oncologic and Orphan Drugs in Germany – Implications for Price Discounts

Abstract

Authors

U. Theidel K. Wahlers T. Mittendorf

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×